1 |
Approaches for recombinant human factor IX production in serum-free suspension cultures do Amaral RLF, Bomfim AD, de Abreu-Neto MS, Picanco-Castro V, Russo EMD, Covas D, Swiech K Biotechnology Letters, 38(3), 385, 2016 |
2 |
Native analysis of plasma-derived clotting factor VIII concentrates: "Sponge effect" and contaminants Blasi B, D'Amici GM, D'Alessandro A, Zolla L Electrophoresis, 33(8), 1292, 2012 |
3 |
Plasma-derived clotting factor VIII: Heterogeneity evaluation in the quest for potential inhibitory-antibody stimulating factors D'Amici GM, Blasi B, D'Alessandro A, Vaglio S, Zolla L Electrophoresis, 32(21), 2941, 2011 |
4 |
Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates Clifton JG, Huang FL, Kovac S, Yang XL, Hixson DC, Josic D Electrophoresis, 30(20), 3636, 2009 |
5 |
Incorporation of blood clotting factor X into phospholipid model membranes: fluorescence microscopy imaging and subphase effects surrounding the lipid phase transition region Craft J, Epps K, Brancato S, Serfis A Journal of Colloid and Interface Science, 268(1), 181, 2003 |